The maximum tolerated chemotherapy enhanced STAT-1 and NF-κB activity in carcinoma-associated fibroblasts, leading to secretion of ELR motif–positive (ELR+) chemokines, which signal through CXCR-2 on carcinoma cells to trigger them to converse to tumor-initiating cells. Here, CXCR2 is linked to carcinoma.